ARCHIVES

Rauscher Explains Reasons for Treatment Switches

This article is from The Cancer Letter archive.

Vol. 01 No. 19 | May 9, 1975

Download PDF Visit The Full Archive

Related Articles

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002